By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Medicus Pharma Ltd. (MDCXW)

NASDAQ Currency in USD
$0.68
-$0.05
-7.41%
Last Update: 12 Sept 2025, 14:37
$39.15M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.66 - $2.50
52 Week Range

MDCXW Stock Price Chart

Explore Medicus Pharma Ltd. interactive price chart. Choose custom timeframes to analyze MDCXW price movements and trends.

MDCXW Company Profile

Discover essential business fundamentals and corporate details for Medicus Pharma Ltd. (MDCXW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

14 Nov 2024

Employees

12.00

CEO

Raza Bokhari MBA

Description

Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets. Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.

MDCXW Financial Timeline

Browse a chronological timeline of Medicus Pharma Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 12 Aug 2025

EPS came in at -$0.43 falling short of the estimated -$0.25 by -72.95%.

Earnings released on 14 May 2025

EPS came in at -$0.42 falling short of the estimated -$0.25 by -68.48%.

MDCXW Stock Performance

Access detailed MDCXW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run